AR and prostate cancer: Interestingly, this specific S599G substitution has been identified in male patients with androgen insensitivity syndrome (AIS) [43], [44] and is catalogued in the McGill University's AR gene mutations database for AIS [http://androgendb.mcgill.ca], but has not been previously linked with prostate cancer.